Artificial calcanei had mechanical characteristics that were different from those of embalmed and fresh frozen cadaveric specimens, which does not support the use of artificial calcanei for mechanical implant testing.
The technique offers a rapid molecular method for the identification of pathogen DNA from human specimens, which does not require the screening of multiple blood films to identify infected red blood cells and provides a molecular basis for species differentiation rather than one based on visual inspection of parasite forms.
Two step tests were performed to evaluate the influence of fatigue induced defects observed in specimens which did not fail within 1010 cycles.
It should be noted that the specimens which did not give rise to proliferating neurospheres were patient #1 (oligoastrocytoma, gradeII) and #7 (anaplastic astrocytoma, grade III), with comparable tumor grades with the other specimens (Additional file 1: Table S1).
Endarterectomy specimens which did not have macroscopically normal areas adjacent to the atheromatous section were age and sex matched with external controls taken from normal post-mortem carotid arteries (8 specimens) following consent from relatives of the deceased.
Previously, there have been some attempts to compare IVCM and histological findings, but these are limited to qualitative comparisons and have employed impression cytology specimens, which do not sample subepithelial tissue.
In addition, low levels of PTP-PEST expression are more common in triple-negative breast cancer specimens, which do not express the genes for estrogen receptor, progesterone receptor, or Her2/neu.
For those EHCC specimens, which did not have inverse correlation of miR-34a and Smad4 expression, we speculate that other factors might antagonize or interfere with the effect of miR-34a on Smad4.
Otherwise the specimens which did not achieve pCR category were classified as residual disease Relapse-free survival (RFS) was determined as the interval between the initiation of neoadjuvant chemotherapy and the date when disease relapse or progression was first documented, or the date of death from any cause.
For control specimen SB1 which does not contain the shear reinforcement, flexural cracks initiated at the bottom of beam at the mid-span, and then the diagonal cracks occurred at the end of the flexural cracks.
